29.09.2023 - Therapeutic Solutions International, Inc. (TSOI) announced today a patent filing covering the unanticipated finding that neutrophils, a type of white blood cell, when manufactured in a specific manner, are capable of stopping unwanted immune .
Investors consistently seek out factors that could influence price fluctuations. A significant catalyst that frequently exerts a profound influence on prices is news. Favorable news possesses the.
ELK CITY, Idaho, September 18, 2023 Therapeutic Solutions International, Inc. (TSOI), announced today the appointment of internationally renowned stem cell therapist Dr. Navneet Boddu to the Company’s Scientific Advisory Board. Dr. Boddu joins eminent luminaries in the regenerative medicine/immunotherapy space such as Dr. Santosh Kesari, Dr. Francesco Marincola1, Dr. Donald Banerji2, and Dr. Boris Minev3.
ELK CITY, Idaho, September 11, 2023 Therapeutic Solutions International, Inc. (TSOI), announced today the development of a new therapeutic approach for treatment of Frontotemporal Dementia, by combining the activation of endogenous anti-inflammatory cells in the nervous system, together with regenerative cell intervention in the form of stem cell therapy, and molecules capable of activating endogenous stem cells already present in the patient.
Landmark Study Aimed to Support FDA Registration of First Cell Therapy with Dual Anti-inflammatory and Lung Healing Mechanism of ActionOCEANSIDE, Calif. (BUSINESS WIRE) Therapeutic Solutions International announced today the launching of a double-blind, randomized, placebo controlled, multi-center, multi-nation, c.